Kevin Haynes
Impact in
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 11
- Hepatology 21
- Liver Disease and Transplantation 19
- Co-authors
- Ronac MamtaniYu‐Xiao YangBen BoursiJames D. LewisMichelle DenburgJoel M. GelfandMary B. LeonardSean Hennessy
- Journals
- Pharmacoepidemiology and Drug Safety (32 papers)Gastroenterology (8 papers)Journal of Clinical Oncology (6 papers)Clinical Trials (5 papers)Clinical Gastroenterology and Hepatology (3 papers)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Kevin Haynes
192 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Applied Microbiology and Biotechnology 151
- Rheumatology 881
- Gastroenterology 285
- Geriatrics and Gerontology 197
- Hepatology 382
Countries citing papers authored by Kevin Haynes
This map shows the geographic impact of Kevin Haynes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Haynes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Haynes more than expected).
Fields of papers citing papers by Kevin Haynes
This network shows the impact of papers produced by Kevin Haynes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Haynes. The network helps show where Kevin Haynes may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Haynes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 4 | |
| 3 | 2021 | 18 | |
| 4 | 2021 | 13 | |
| 5 | 2021 | 13 | |
| 6 | 2020 | 13 | |
| 7 | Abstract 14740: Achieving Guideline-Directed Therapy in U.S. Patients With Diabetes and Cardiovascular Disease: Alarming Gaps, Compelling Opportunities | 2019 | 2 |
| 8 | 2017 | 28 | |
| 9 | 2016 | 9 | |
| 10 | 2015 | 47 | |
| 11 | 2015 | 60 | |
| 12 | 2015 | 46 | |
| 13 | 2014 | 15 | |
| 14 | Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study Hit paper breakdown → | 2014 | 354 |
| 15 | 2012 | 87 | |
| 16 | 2012 | 107 | |
| 17 | 2009 | 40 | |
| 18 | 2008 | 25 | |
| 19 | 2007 | 31 | |
| 20 | 1995 | 52 |
About Kevin Haynes
Kevin Haynes is a scholar working on Geriatrics and Gerontology, Hepatology, Toxicology, Applied Microbiology and Biotechnology and Family Practice, having authored 195 papers that have together received 6.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (20 papers), Liver Disease and Transplantation (19 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers), Metabolism, Diabetes, and Cancer (13 papers), Pharmaceutical Practices and Patient Outcomes (11 papers), Pharmacovigilance and Adverse Drug Reactions (9 papers), Diabetes Treatment and Management (9 papers) and Gastroesophageal reflux and treatments (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (151 citations), Rheumatology (881 citations), Gastroenterology (285 citations), Geriatrics and Gerontology (197 citations) and Hepatology (382 citations). Kevin Haynes has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Ronac Mamtani, Yu‐Xiao Yang, Ben Boursi, James D. Lewis, Michelle Denburg, Joel M. Gelfand, Mary B. Leonard, Sean Hennessy, Theoklis E. Zaoutis and Andrea B. Troxel. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Gastroenterology, Journal of Clinical Oncology, Clinical Trials and Clinical Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.